Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time

Author(s):  Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R

Issue:  Sep/Oct 2012 - Volume 16, Number 5
View All Articles in Issue

Page(s):  431-433

Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Page 1
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Page 2
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Page 3

Download in electronic PDF format for $75

Abstract:  PhaSeal is a closed-system drug transfer device which has demonstrated to protect against occupational exposure to antineoplastic agents. Our aim was to assess the impact of the incorporation of PhaSeal on the processing time of chemotherapy. The study was a prospective simulation study which compared the processing times with the traditional open-system technique and using the closed-transfer system. Four experienced pharmacy technicians prepared six batches with each method simulating simple chemotherapy admixture operations. We compared the mean times obtained by student's t test and evaluated the “learning effect” between days by ANOVA. The average percentage of time saving with PhaSeal was 31.7% (time per batch [mean±SD] 6.44+0.73 vs. 9.44+0.98 minutes). Mean difference was statistically significant (3.0 min IC95% 2.50-3.50; p>0.0001). No significant learning curve effect was detected. The BD Medical/Carmel Pharma PhaSeal system, in addition to its protective properties, is able to save time in the elaboration process which leads to organization advantages for hospital pharmacy services.

Related Keywords: closed-system drug transfer, chemotherapy agents, occupational exposure, preparation time

Related Categories: CANCER AND AIDS, PEER-REVIEWED, TECHNOLOGY, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Sanchez-Rubio Ferrandez J
, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Sep/Oct 2012
Pg. 431-433

Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe
, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Mar/Apr 2016
Pg. 148-154

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Jan/Feb 2022
Pg. 72-79

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021
Pg. 515-522

Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal
, Rios GL Quito
Sep/Oct 2022
Pg. 358-362

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes
de Wilde Sofieke
, Crul Mirjam, Breukels Oscar
Mar/Apr 2023
Pg. 154-159

Comparison of Three Reconstitution Devices: A Simulated Time and Use Study
Penoyer Daleen
, Giuliano Karen, Middleton Aurea
Mar/Apr 2023
Pg. 169-174

Basics of Compounding for the Treatment of Warts
Allen Loyd V Jr
Mar/Apr 2004
Pg. 126-129

A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
Mar/Apr 2014
Pg. 94-99

Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance
Grilli Anthony
, Sutton Scott
Jan/Feb 2015
Pg. 30-37

The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Pore R David
Nov/Dec 2012
Pg. 446-450

Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Taghi Hassanien Sagban
, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jul/Aug 2023
Pg. 340-346

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
Nov/Dec 2012
Pg. 456-460

How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A
, Gehrmann Matthew R, McCaw James, McAndrew T Page
Nov/Dec 2019
Pg. 454-461

Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek
, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018
Pg. 108-121

Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
Jul/Aug 2011
Pg. 308-315

Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
Jul/Aug 2013
Pg. 307-311

Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
Nov/Dec 2006
Pg. 446-448

Compounding Using Hazardous Drugs
Lau Kellie
Jul/Aug 2000
Pg. 261-263

Return to Top